Simplex Trading, LLC Sol Gel Technologies Ltd. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$0.52 - $1.3 $119 - $297	229 Added 848.15%	256 $0
Q4 2024 Feb 11, 2025	BUY	$0.43 - $1.65 $11 - $44	27 New	27 $0
Q2 2024 Jul 25, 2024	BUY	$0.66 - $1.05 $132 - $210	200 Added 38.02%	726 $0
Q1 2024 Apr 25, 2024	BUY	$0.95 - $1.5 $499 - $789	526 New	526 $0
Q1 2023 Apr 27, 2023	BUY	$3.44 - $5.32 $1,506 - $2,330	438 Added 202.78%	654 $2,000
Q4 2022 Feb 02, 2023	BUY	$4.26 - $5.22 $920 - $1,127	216 New	216 $0
Q2 2022 Aug 03, 2022	SELL	$4.1 - $7.36 $9,721 - $17,450	-2,371 Reduced 91.72%	214 $0
Q1 2022 May 02, 2022	BUY	$6.64 - $8.21 $10,424 - $12,889	1,570 Added 154.68%	2,585 $19,000
Q4 2021 Feb 23, 2022	BUY	$6.57 - $9.78 $6,668 - $9,926	1,015 New	1,015 $7,000

123K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $828M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.